Quantification of Tumor Microvascularity with Respiratory Gated Contrast Enhanced Ultrasound for Monitoring Therapy

Ultrasound in Medicine and Biology

Volumn 36, Issue 1, 2010, Pages 68-77

  Averkiou, Michalakis ^a   Lampaskis, Marios ^a   Kyriakopoulou, Konstantina ^b   Skarlos, Dimosthenis ^d   Klouvas, Georgios ^d   Strouthos, Costas ^a   Leen, Edward ^c  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b HENRY DUNANT HOSPITAL   (Greece)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d METROPOLITAN HOSPITAL   (Greece)

Author keywords

Liver metastasis; Perfusion quantification; Respiratory gating; Therapy monitoring; Ultrasound contrast agents

Indexed keywords

LIVER METASTASIS; PERFUSION QUANTIFICATION; RESPIRATORY GATINGS; THERAPY MONITORING; ULTRASOUND CONTRAST AGENT;

ACOUSTIC WAVES; DIAPHRAGMS; IMAGING TECHNIQUES; LIVER; PATHOLOGY; RESOURCE ALLOCATION; RESPIRATORY MECHANICS; SULFUR; SULFUR HEXAFLUORIDE; TUMORS; ULTRASONIC IMAGING; ULTRASONICS; ULTRASONOGRAPHY;

POSITRON EMISSION TOMOGRAPHY;

BEVACIZUMAB; CAPECITABINE; IRINOTECAN; OXALIPLATIN; SONOVUE;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG RESPONSE; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; GATED IMAGING; HUMAN; LIVER METASTASIS; LIVER PARENCHYMA; LIVER PERFUSION; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TUMOR VASCULARIZATION;

AGED; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; CONTRAST MEDIA; CYTOTOXINS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RESPIRATION; SULFUR HEXAFLUORIDE; TREATMENT OUTCOME;

EID: 71849094546     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2009.07.005     Document Type: Article

References (31)

1. Arditi M., Frinking P.J.A., Zhou X., and Rognin N.G. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 53 (2006) 1118-1229
2. Averkiou M., Powers J., Skyba D., Bruce M., and Jensen S. Ultrasound contrast imaging research. Ultrasound Q 19 (2003) 27-37
3. Averkiou M.A., Bruce M., Jensen S., Rafter P., Brock-Fisher T., and Powers J. Pulsing schemes for the detection of nonlinear echoes from contrast microbubbles (January 2004), 9th European Symposium on Ultrasound Contrast Imaging, Rotterdam, The Netherlands 17-24
4. Averkiou M.A., Lampaskis M., Kyriakopoulou K.N., Klouvas G., Skarlos D., and Leen E. Quantification of tumor microvascularity with respiratory gated contrast enhanced US for monitoring therapy, ESGAR. Valencia, Spain (2009) (in press)
5. Bekradda M., and Cvitkovic E. New possibilities in chemotherapy for colorectal cancer. Annals of Oncology Suppl. 6 (1999) S105-S111
6. Blomley M.J.K., and Dawson P. Bolus dynamics: Theoretical and experimental aspects. Br J Radiol 70 (1997) 351-359
7. Browder T., Butterfield C.E., Kraling B.M., Shi B., Marshall B., O'Reilly M.S., and Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60 (2000) 1878-1886
8. Correas J.M., Tranquart M.C.F., and Helenon O. The kidney: Imaging with microbubble contrast agents. Ultrasound Q 22 (2006) 53-66
9. Elie N., Kaliski A., Pronneau P., Opolon P., Roche A., and Lassau N. Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. Ultrasound Med Biol 33 (2007) 549-560
10. Ferrara K., Merritt C., Burns P., Foster F.S., Mattrey R.F., and Wickline S.A. Evaluation of tumor angiogenesis with us: Imaging, Doppler and contrast agents. Acad Radiol 7 (2000) 824-839
11. Fisher N.G., Christiansen P.C., Leong-Poi H., Jayaweera A.R., Lidner J.R., and Kaul S. Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. J Am Coll Cardiol 39 (2002) 530-537
12. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Nat Cancer Inst 82 (1990) 4-6
13. Folkman J. Angiogenesis: An organizing principle for drug discovery?. Nat Rev Drug Discov 6 (2007) 273-286
14. Görg C. The forgotten organ: Contrast enhanced sonography of the spleen. Eur J Radiol 64 (2007) 189-201
15. Jain R.K. Taming vessels to treat cancer. Sci Am 298 (2008) 56-63
16. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
17. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
18. Kerbel R.S. Antiangiogenic therapy: A universal chemosensitization strategy for cancer?. Science 312 (2006) 1171-1174
19. Lassau N., Chami L., Benatsou B., Peronneau P., and Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: A new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol Suppl 17 Suppl. 6 (2007) F89-F98
20. Leen E., Ceccotti P., Moug S.J., Glen P., MacQuarrie J., Angerson W.J., Albrecht T., Hohmann J., Oldenburg A., Ritz J.P., and Horgan P.G. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: An essential investigation before resection?. Ann Surg 243 (2006) 236-240
21. Leen E., Ceccotti P., Kalogeropoulou C., Angerson W.J., Moug S.J., and Horgan P.G. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. Am J Roentgenol 186 (2006) 1551-1559
22. Miller C.M., Pien H.H., Shani D., Sorensen A.G., and Thrall J.H. Imaging angiogenesis: Applications and potential for drug development. J Nat Cancer Inst 97 (2005) 172-187
23. Mischi M., Kalker T., and Korsten E. Videodensitometric methods for cardiac output measurements. EURASIP J Appl Signal Proc 5 (2003) 479-489
24. Mischi M., Den Boer J.A., and Korsten H.H.M. On the physical and stochastic representation of an indicator dilution curve as a gamma variate. Physiol Meas 29 (2008) 281-294
25. Pandharipande P.V., Krinsky G.A., Rusinek H., and Lee V.S. Perfusion imaging of the liver: Current challenges and future goals. Radiology 234 (2005) 661-673
26. Qian H., and Bassingthwaighte J.B. A class of flow bifurcation models with lognormal distribution and fractal dispersion. J Theor Biol 205 (2000) 261-268
27. Quaia E., Palumbo A., Rossi S., Degobbis F., Cernic S., Tona G., and Cona M. Comparison of visual and quantitative analysis for characterization of insonated liver tumors after microbubble contrast injection. Am J Roentgenol 186 (2006) 1560-1570
28. Rizzatto G., Martegani A., Chersevani R., Macorig D., Vrtovec M., Aiani L., and Tufarulo. Importance of staging of breast cancer and role of contrast ultrasound. Eur Radiol 11 Suppl. 3 (2001) E47-E52
29. Renault G., Tranquart F., Perlbarg V., Bleuzen A., Herment A., and Frouin F. A posteriori respiratory gating in contrast ultrasound for assessment of hepatic perfusion. Phys Med Biol 20 (2005) 4465-4480
30. Schlosser T., Pohl C., Kuntz-Hehner S., Omran H., Becher H., and Tiemann K. Echoscintigraphy: A new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography. Ultrasound Med Biol 29 (2003) 985-991
31. Wei K., Jayaweera A.R., Firoozan S., Firoozan S., Linka A., Skyba D.M., and Kaul S. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: Bolus or continuous infusion?. J Am Coll Cardiol 32 (1998) 252-260